BRAINSTORM CELL THERAPEUTICS's ticker is BCLI and the CUSIP is 10501E201. A total of 59 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q3 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $2,310 | -13.2% | 700 | 0.0% | 0.00% | – |
| Q2 2021 | $2,660 | -0.8% | 700 | 0.0% | 0.00% | – |
| Q1 2021 | $2,681 | -15.4% | 700 | 0.0% | 0.00% | – |
| Q4 2020 | $3,168 | -53.2% | 700 | +75.0% | 0.00% | – |
| Q3 2020 | $6,768 | +268.8% | 400 | -14.5% | 0.00% | – |
| Q4 2017 | $1,835 | -4.8% | 468 | 0.0% | 0.00% | – |
| Q3 2017 | $1,928 | – | 468 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EAM Investors, LLC | 129,929 | $603,000 | 0.19% |
| ABNER HERRMAN & BROCK LLC | 56,050 | $260,000 | 0.06% |
| CFO4Life Group, LLC | 12,000 | $56,000 | 0.03% |
| Spark Investment Management LLC | 12,000 | $55,000 | 0.03% |
| Phoenix Holdings Ltd. | 118,533 | $534,000 | 0.03% |
| HighPoint Advisor Group LLC | 13,533 | $82,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 12,500 | $58,000 | 0.02% |
| ETF MANAGERS GROUP, LLC | 66,197 | $299,000 | 0.01% |
| WINTON GROUP Ltd | 76,967 | $357,000 | 0.01% |
| IHT Wealth Management, LLC | 13,000 | $60,000 | 0.01% |